• Return to Headlines

Cytomx Therapeut Has Returned 19.8% Since SmarTrend Recommendation (CTMX)

By Amy Schwartz

SmarTrend identified a Downtrend for Cytomx Therapeut (NASDAQ:CTMX) on February 27th, 2019 at $12.97. In approximately 2 weeks, Cytomx Therapeut has returned 19.78% as of today's recent price of $10.40.

Cytomx Therapeut share prices have moved between a 52-week high of $34.98 and a 52-week low of $9.38 and are now trading 11% above that low price at $10.40 per share. In the last five trading sessions, the 50-day moving average (MA) has fallen 2.3% while the 200-day MA has slid 1.6%.

CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops a novel class of investigational antibody therapeutics based on its Probody technology platform for the treatment of cancer.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Cytomx Therapeut.

Log in and add Cytomx Therapeut (CTMX) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights cytomx therapeut

Ticker(s): CTMX